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Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is an important
nosocomial agent of biopolymer-associated infections, and iso-
lates of S. aureus can produce different virulence factors, includ-
ing potent toxins. The bioﬁlm formation and accumulation by
certain international MRSA lineages were analysed, and the toxic
shock syndrome-associated genes (tst, seb and sec) among these
isolates were assessed. In addition, the presence of lukF-pv
(encoding the F-subunit of Panton–Valentine leukocidin (PVL))
was investigated. Most of the MRSA isolates tested were capable
of forming bioﬁlm on polystyrene surfaces, but lacked the super-
antigen toxin genes that were tested. PVL was rarely detected
among the hospital isolates analysed.
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The increasing use of invasive medical procedures has
resulted in the augmentation of bioﬁlm-associated nosoco-
mial infections [1]. Staphylococcus aureus and Staphylococcus
epidermidis are the most important species of the genus
Staphylococcus involved in this type of disease [2]. Both spe-
cies harbor the ica operon (encoding enzymes involved in
the biosynthesis of polysaccharide intercellular adhesin).
Despite strong evidence that polysaccharide intercellular
adhesin seems to be a central bioﬁlm mediator of S. epidermi-
dis, ica-independent bioﬁlm pathways have been identiﬁed
[3,4]. In Brazil, and in other countries, including the USA,
c. 60% of hospital isolates of S. aureus are methicillin-resistant
S. aureus (MRSA) [5,6]. However, bioﬁlm formation by the
different MRSA lineages has not been studied in detail.
Although the most important virulence factor of S. epidermidis
seems to be the ability to adhere to medical biopolymers,
the pathogenicity of S. aureus is considered to be multifacto-
rial and related to a number of virulence traits that are
expressed by the microorganism, and are coordinated by a
synchronized and intricate process of gene regulation [7].
MRSA strains producing superantigen toxins, including toxic
shock syndrome toxin-1, staphylococcal enterotoxin B (SEB)
and staphylococcal enterotoxin C (SEC), have been impli-
cated in staphylococcal toxic shock syndrome [7].
Panton–Valentine leukocidin (PVL), which is frequently
found in community-acquired MRSA (CA-MRSA) strains, is
another potent S. aureus toxin that has been associated with
necrotizing pneumonia [8].
Bioﬁlm formation among isolates of certain international
MRSA lineages was analysed and compared with that of
methicillin-resistant S. epidermidis (MRSE) isolates. Addition-
ally, the distribution of the genes encoding the toxins SEB,
SEC, toxic shock syndrome toxin (TST) and PVL among
MRSA isolates was assessed.
Fifty-one MRSA isolates obtained from different clinical
specimens (29 from blood, 21 from miscellaneous sites, and
one of non-reported origin) were analysed for bioﬁlm forma-
tion and accumulation. The majority of the isolates were
obtained from hospitals located in Brazil, with the exception
of the isolates belonging to the USA100 and USA200 types,
which were obtained from US hospitals. The MRSA ST30-
SCCmecIV isolates (Oceania Southwest Paciﬁc-OSP) clone)
were obtained from individuals with community-acquired
infections in Brazil. These isolates were characterized using
pulsed-ﬁeld gel electrophoresis (PFGE) [9], SCCmec typing
[10], and multilocus sequence typing (MLST) (http://
www.mlst.net). One isolate of each PFGE type was used for
MLST studies. The criteria used for the analysis of the PFGE
patterns were those described by Tenover et al. [11]. Four-
teen isolates belonged to the Brazilian epidemic clone BEC
(ST239-SCCmecIIIA), ﬁve isolates to the New York/Japan
clone USA100 (ST5-SCCmecII), nine to the EMRSA-16-
USA200 clone (ST36-SCCmecII), 14 to the WA-1-USA400
clone (ST1-SCCmecIV), and nine to the Oceania Southwest
Paciﬁc-OSP clone (ST30-SCCmecIV). In total, 21 MRSE clini-
cal isolates obtained from a Brazilian hospital (19 from blood
and two from other clinical sources) were included for com-
parative analysis of bioﬁlm formation and accumulation in
these two species. Bioﬁlm assays were performed using Try-
pticase soy broth with 1% glucose in an inert polystyrene
microtitre plate (Nuclon; Nalge Nunc International, Roches-
ter, NY, USA) and the bioﬁlm unit (BU) was calculated as
described previously [5]. The isolates were classiﬁed as bio-
ﬁlm non-producers (BU £ 0.23), weak producers
(0.23 < BU £ 0.46), moderate producers (0.46 < BU £ 0.92)
or strong producers (BU > 0.92). Ampliﬁcations of gene
fragments by PCR were carried out as described previously,
using speciﬁc primers speciﬁc for the seb [12] sec [12], tst
[13] and lukF-pv loci [14]. The microtitre plate assay is rec-
ommended for screening multiple isolates [15]. This test has
been validated using confocal laser scanning microscopy (L.R.
Coelho, R.R. Souza, F.A. Ferreira, M.A. Guimara˜es, B.T.
Ferreira-Carvalho, A.M. Figueiredo, unpublished data). Other
researchers have shown that there is a good correlation
between glucose-induced bioﬁlm development by S. aureus
in vitro (under static or ﬂow conditions) and in vivo [16,17].
The majority of the MRSA isolates (46/51; 90%) and
approximately half of the MRSE isolates (11/21; 52%) were
able to form bioﬁlm (Table 1). Similar results for MRSE were
obtained previously, using a totally different bacterial collec-
tion [18]. However, when only the bioﬁlm producers were
analysed, there was no signiﬁcant difference between the
mean BU values in the populations formed by MRSA and
those formed by MRSE (Table 1). The BU means for bioﬁlm
producers were 0.789 ± 0.573 and 1.142 ± 0.977 for MRSA
and MRSE, respectively. There was no signiﬁcant difference
when the production of bioﬁlm of MRSA isolated from blood
(0.809 ± 0.63) was compared with that of MRSA obtained
from diverse clinical sources (0.617 ± 0.5). However, it was
observed that isolates of ST239-SCCmecIIIA showed the
highest ability to accumulate bioﬁlm (1.236 ± 0.71), followed
by ST1-SCCmecIV (0.815 ± 0.59). According to these results
57% and 29% of the ST239-SCCmecIIIA and ST1-SCCmecIV
204 Clinical Microbiology and Infection, Volume 15 Number 2, February 2009 CMI
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 200–207
isolates, respectively, were classiﬁed as strong bioﬁlm pro-
ducers (data not shown). There was no signiﬁcant difference
between the mean BU values for these two MRSA lineages,
nor was a signiﬁcant difference found among the BU means
for the moderate bioﬁlm-producing populations formed by
ST5-SCCmecII (0.513 ± 0.205), ST36-SCCmecII (0.425 ±
0.171) and ST30-SCCmecIV (0.584 ± 0.239). However, the
differences among the BU means for the three populations
above and the populations formed by ST239-SCCmecIIIA,
ST1-SCCmecIV or MRSE isolates were considered to be
signiﬁcant (p 0.0001, p 0.0061 and p 0.0362, respectively).
These results conﬁrm our previous ﬁnding that ST239-
SCCmecIIIA isolates have an enhanced ability to form bioﬁlm
[5]. Studying an outbreak in an intensive-care unit of a hospi-
tal located in the UK, Edgeworth et al. showed that patients
who acquired a variant (TW) of the ST239-SCCmecIIIA iso-
lates were more likely to have MRSA isolated from blood
and vascular access device sample cultures (p <0.001) than
were patients who harboured other MRSA strains [19].
Although these authors did not study the bioﬁlm production
of the outbreak strain, their ﬁndings can be explained by the
superior ability of those isolates to produce bioﬁlm, as
shown here and previously [5].
Most of the CA-MRSA isolates studied here (ST1-SCCme-
cIV and ST30-SCCmecIV) were able to produce bioﬁlm (20/
23 isolates tested) (Table 1). CA-MRSA isolates belonging to
other lineages (ST59-SCCmecIV and ST59-SCCmecV) were
also able to form bioﬁlm [20]. The great majority of the CA-
MRSA ST1-SCCmecIV (WA-1/USA400) isolates from Brazil
were involved in hospital infections. It is also of importance
that ST1-SCCmecIV isolates has recently replaced ST239-
SCCmecIIIA in a Brazilian hospital (A. M. S. Figueiredo, R.R.
Souza, L.R. Coelho, A.M.N. Botelho, A. Ribeiro, P.N. Rito,
V.V. Vieira, L.A. Teixeira, B.T. Ferreira-Carvalho, A.M.S. Fi-
gueiredo, unpublished data). Because many nosocomial infec-
tions are directly associated with the use of implantable
medical devices [1], the accentuated bioﬁlm-forming capabil-
ity demonstrated by ST1-SCCmecIV isolates may be, at least
in part, explained by the prevalence of these CA-MRSA iso-
lates in hospital-associated diseases.
To assess the genes encoding SEB, SEC, TST and PVL,
several more S. aureus hospital isolates were included
(Table 2). Fifty isolates were hospital isolates of methicillin-
susceptible S. aureus (MSSA) from Brazil, 100 belonged to
the ST239-SCCmecIIIA lineage, 37 belonged to a population
formed by ST1-SCCmecIV, ST5-SCCmecII, ST30-SCCmecIV
and ST36-SCCmecII, and ﬁnally, 50 MRSA isolates belonged
to sporadic clones (MRSA strains rarely detected in Brazilian
hospitals). The results showed that the genes tested were
rarely detected among the isolates analysed, except for lukF-
pv, which was present in all ST30-SCCmecIV isolates
(Table 2). Similar results have been reported previously
[14,21,22]. In contrast to the ST1-SCCmecIV isolates from
the USA, the ST1-SCCmecIV isolates from Brazil resemble
the Australian WA-1 isolates, in that they do not have PVL
genes (Table 2) [21]. The coexistence of PVL-positive and
PVL-negative USA400 isolates, sharing otherwise identical
genotypic and phenotypic properties as well as associated
clinical characteristics, was detected in Canada [23].
Among the hospital isolates, lukF-pv was detected in only
two isolates that belonged to ST239-SCCmecIIIA (2/100),
one sporadic MRSA isolate (1/50), and two MSSA isolates (2/
50), corresponding to 2.3% (5/214) (Table 2). These results
showed that, also in Brazil, PVL is rarely detected among
MRSA and MSSA hospital isolates [22,24]. The presence of
TABLE 2. Detection of the genes encoding Panton–Valentine leukocidin (lukF-pv), staphylococcal enterotoxins B and C (seb
and sec) and toxic shock syndrome toxin (tst) among Staphylococcus aureus clinical isolates
Gene
ST5-SCCmecII
(ﬁve isolates)
ST239-SCCmecIIIA
(100 isolates)
ST1-SCCmecIV
(14 isolates)
ST30-SCCmecIV
(nine isolates)
ST36-SCCmecIV
(nine isolates)
Sporadic
(50 isolates)
MSSA
(50 isolate)
lukF-pv NA 2 (2%) NA 9 (100%) NA 1 (2%) 2 (4%)
seb NA NA ND ND NA 4 (8%) 3 (6%)
sec NA 1 (1%) ND ND NA NA NA
tst NA NA ND ND NA NA 1 (2%)
MSSA, methicillin-susceptible S. aureus; NA, no ampliﬁcation was detected with the speciﬁc primers; ND, not done.
TABLE 1. Bioﬁlm formation and accumulation by isolates
of methicillin-resistant Staphylococcus aureus (MRSA) inter-
national lineages and by methicillin-resistant Staphylococcus
epidermidis (MRSE) isolates
Strain
Bioﬁlm
producers/ total
isolates tested
BU mean
(± SD)
MRSA 46/51 0.789 (±0.573)
ST239-SCCmecIIIA 13/14 1.236 (±0.710)
ST1-SCCmecIV 11/14 0.815 (±0.590)
ST30-SCCmecIV 9/9 0.584 (±0.239)
ST5-SCCmecII 5/5 0.513 (±0.205)
ST36-SCCmecII 8/9 0.425 (±0.171)
MRSE 11/21 1.142 (±0.977)
BU, bioﬁlm unit (calculated for the population formed by the isolates classiﬁed
as bioﬁlm producers); SD, standard deviation.
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the tst, sec and seb genes was also rarely detected among the
hospital isolates analysed. The seb gene was detected in
three MSSA isolates (3/50) and in four sporadic isolates
(4/50), accounting together for 3.3% of the total isolates
analysed (7/214). The sec and tst genes were detected in only
one ST239-SCCmecIIIA isolate (1/100) and in one MSSA iso-
late (1/50), respectively (Table 2). Kim et al. [25] observed
that none of the MRSA isolates of the SCCmecIII type
carried the seb, sec or tst genes. In contrast to what was
found in this study, these authors found that 75% of the
SCCmecII isolates had both the sec and tst genes. In addition,
47% of the SCCmecIV isolates carried the seb gene and 19%
the tst gene. However, they did not fully characterize the
lineages involved in their study, as further molecular typing
(i.e. MLST) was not carried out. Toxic shock syndrome
toxin-1-producing MRSA isolates (ST5 and ST30) associated
with outbreaks of nosocomial toxic shock syndrome have
also been observed in France and in Japan [24]. Despite the
fact that these toxin genes are carried by mobile genetic
elements and, thus, could theoretically be present or absent
in different isolates of a speciﬁc lineage, the existence of a
correlation of speciﬁc clone type and superantigen proﬁles,
in a hospital or in a geographical area, should be investigated
in order to trace potential staphylococcal toxic shock
syndrome-associated isolates.
Considered together, these data demonstrate that varia-
tions can occur in virulence traits among isolates of a speciﬁc
lineage, and it is possible that this variability may contribute
to the predominance of more adapted (more virulent) vari-
ants during an outbreak or within a speciﬁc epidemiological
scenario.
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